Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Thu 24 Jun 2010, 7:47 AIP - Adcock Ingram - Adcock Ingram and MSD (South Africa) enter into strategic
AIP
AIP                                                                             
AIP - Adcock Ingram - Adcock Ingram and MSD (South Africa) enter into strategic 
co-promotion and distribution agreements and withdrawal of cautionary           
announcement                                                                    
Adcock Ingram Holdings Limited                                                  
(Incorporated in the Republic of South Africa)                                  
Registration number 2007/016236/06                                              
Share code: AIP                                                                 
ISIN: ZAE000123436                                                              
("Adcock Ingram")                                                               
ADCOCK INGRAM AND MSD (SOUTH AFRICA) ENTER INTO STRATEGIC CO-PROMOTION AND      
DISTRIBUTION AGREEMENTS AND WITHDRAWAL OF CAUTIONARY ANNOUNCEMENT               
Shareholders are advised that Adcock Ingram has entered into a five-year        
strategic collaboration to co-promote and distribute a number of established MSD
products.  MSD is a trade name of Merck & Co., Inc. ("Merck"), with headquarters
in Whitehouse Station, New Jersey, USA.  The MSD products that will be co-      
promoted by MSD and Adcock Ingram include MSD`s over-the-counter products       
currently registered in South Africa and selected prescription medicines.       
MSD is a global healthcare leader with a presence in more than 140 countries and
is currently ranked number 8 in South Africa in a survey conducted by IMS       
Health, the world`s leading provider of market intelligence to the              
pharmaceutical and healthcare industries.  The collaboration between MSD and    
Adcock will be managed by a Joint Operating Committee consisting of management  
members of both companies.                                                      
The financial effects of the transaction are not material.                      
Adcock Ingram shareholders are advised that the cautionary announcement dated   
Monday, 21 June 2010 relating to this transaction is withdrawn.  Adcock Ingram  
shareholders should, however, note that Adcock is still trading under cautionary
as a result of the transaction relating to the initiation of the call option    
process by Baxter Healthcare SA and should continue to exercise caution when    
dealing in Adcock Ingram securities until a further announcement is made.       
Midrand                                                                         
24 June 2010                                                                    
Sponsor                                                                         
Deutsche Securities (SA) (Proprietary) Limited                                  
Date: 24/06/2010 07:47:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: